Continental General Recaptures LTC Risk from Munich Re, Enhancing Asset Base
Continental General Insurance completes risk recapture from Munich Re on life and long-term care policies, boosting assets and reserves with full risk assumption.
Continental General Insurance completes risk recapture from Munich Re on life and long-term care policies, boosting assets and reserves with full risk assumption.
Cambodia's life insurance sector shows steady growth in 2025 with Forte Life Assurance turning profitable. Improved bancassurance regulations and digital distribution drive market expansion amid economic shifts.
Canara HSBC Life Insurance announces EZ Pension Plan via Policybazaar, targeting retirement savings with flexible, market-linked growth tailored for India’s ageing population.
Review Q2 earnings for top U.S. life insurers including CNO, Corebridge, Prudential, highlighting market resilience amid interest rate shifts and competitive pressures.
U.S. insurers enhance websites to meet rising consumer expectations, focusing on interaction, privacy, and service amid digital marketing changes. Industry lags in innovation but sees improvements in content and responsiveness.
Most employer life insurance provides only 2x salary coverage, below the recommended 10-15x. Term life insurance can supplement to better secure family financial protection.
A leading Third-Party Administrator adopts CalcFocus Achieve and Forecast systems to modernize policy administration, enhance digital service, and accelerate Life and Annuity product deployment.
Swiss Re's August 2025 Life Guide update provides U.S. life insurers with new underwriting guidance on repurposed longevity drugs like metformin and rapamycin, enhancing risk assessment for evolving health trends.
Wealth Express introduces term life insurance with guaranteed rates and no medical exams, eliminating hidden fees common in digital platforms. Transparent pricing restores consumer trust.
Swiss Re updates its Life Guide to help underwriters assess life insurance risks related to repurposed longevity drugs like metformin and rapamycin, enhancing medical risk evaluation and underwriting consistency across global markets.